SynthesisFrontiers in pharmacology2026

Risk of neoplasms with semaglutide in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.

Yuanyuan Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.